Evidence map›Paper›PMID 20186991›Full record

ArticleClinical cardiology2010

Gender differences in the treatment of non-ST-segment elevation myocardial infarction.

Dale Tavris, Azadeh Shoaibi, Anita Y Chen, Takahiro Uchida, Matthew T Roe, Jiping Chen

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Clinical cardiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Observational
  5. Article
  6. Article
  7. Observational
  8. Assessing and Modifying Coronary Artery Disease Risk in Women.Current treatment options in cardiovascular medicine · 2017
    Review
  9. Review
  10. Article
  11. Acute coronary syndromes in women and men.Nature reviews. Cardiology · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Examining sex and gender disparities in total joint arthroplasty.Clinical orthopaedics and related research · 2011
    Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Dale TavrisFood and Drug Administration, Center for Devices and Radiological Health, Division of Epidemiology, USA. dale.tavris@fda.hhs.gov
Azadeh Shoaibi
Anita Y Chen
Takahiro Uchida
Matthew T Roe
Jiping Chen
Center for Devices and Radiological Health · USClinical Research Institute · USBoston Scientific (Netherlands) · NLFood and Drug Administration · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWomen are at greater risk for worse outcomes associated with acute coronary syndrome (ACS) than are men. One explanation may be that they tend to be treated less aggressively than men even when more aggressive treatment is warranted. The purpose of this analysis was to assess this issue.

methodsWe used the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation (CRUSADE) Quality Improvement Initiative registry, an observational data collection that began in November 2001, with retrospective data collection from January 2001 to December 2006. A total of 32,888 subjects met the inclusion/exclusion criteria for our study, based on strong biochemical evidence of myocardial infarction and acute onset of typical cardiac chest pain. We stratified subjects into 16 cells for coronary intervention, based on 4 age groups and 4 cardiac catheterization findings (insignificant, 1-vessel disease, 2-vessel disease, 3-vessel disease). We also stratified subjects into 20 cells for medical treatment, based on 4 age groups and 5 medical treatments. In each cell we compared the rate of coronary intervention (coronary artery bypass grafting or percutaneous coronary intervention) or medical treatment (glycoprotein IIb/IIIa inhibitors, aspirin, clopidogrel, beta-blocker, and statins) for men vs women.

resultsMen demonstrated significantly higher rates (P < 0.05) of coronary intervention in 7 of the 16 cells and 9 of the 20 medical treatment cells, compared to no cells in which women had statistically higher rates than men.

conclusionThese findings suggest that men are more likely than women to receive coronary intervention and to be medically treated when presenting with evidence of non-ST-segment myocardial infarction, controlled for age, cardiac catheterization findings, and biochemical evidence of myocardial infarction.

Indexed as

Angioplasty, Balloon, CoronaryCoronary Artery BypassHealthcare DisparitiesPractice Patterns, Physicians'AgedAged, 80 and overAge FactorsAngina, UnstableCardiovascular AgentsChi-Square DistributionCoronary AngiographyCoronary Artery DiseaseFemaleHumansMaleMiddle AgedCardiovascular Agents

Identifiers

PMID20186991
PMCPMC6652882
OpenAlexW2765266954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.